Q3 2023 Holdings
Filed 2023-11-14 | 19 holdings | $85.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Moonlake Immunotherapeutics(MLTX) | CLASS A ORD | 61559X104 | $10.4M | 183,105 | 12.3% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $9.1M | 266,961 | 10.7% |
| Intra-Cellular Therapies Inc(ITCIEUR) | COM | 46116X101 | $9.1M | 175,000 | 10.7% |
| Axsome Therapeutics Inc(AXSM) | COM | 05464T104 | $7.7M | 110,600 | 9.1% |
| Apellis Pharmaceuticals Inc(APLS) | COM | 03753U106 | $6.9M | 181,805 | 8.1% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $6.6M | 223,382 | 7.7% |
| Merus NV | COM | N5749R100 | $5.2M | 221,384 | 6.1% |
| Amylyx Pharmaceuticals Inc(AMLX) | COM | 03237H101 | $5.0M | 272,690 | 5.9% |
| Geron Corp(GERN) | COM | 374163103 | $4.7M | 2,221,639 | 5.5% |
| Ardelyx Inc(ARDX) | COM | 039697107 | $3.6M | 881,356 | 4.2% |
| Ambrx Biopharma Inc | SPONSORED ADS | 02290A102 | $3.2M | 281,089 | 3.8% |
| Mirati Therapeutics Inc(MRTXEUR) | COM | 60468T105 | $3.1M | 70,283 | 3.6% |
| Jasper Therapeutics Inc | COM | 471871103 | $2.2M | 3,144,164 | 2.6% |
| Black Diamond Therapeutics I(BDTX) | COM | 09203E105 | $1.8M | 634,191 | 2.1% |
| Praxis Precision Medicines I | COM | 74006W108 | $1.8M | 1,056,370 | 2.1% |
| Compass Therapeutics Inc(CMPX) | COM | 20454B104 | $1.8M | 914,630 | 2.1% |
| Context Therapeutics Inc(CNTX) | COM | 21077P108 | $1.1M | 725,951 | 1.3% |
| Promis Neurosciences Inc(PMNEUR) | COM NEW | 74346M406 | $1.1M | 531,915 | 1.2% |
| Medavail Holdings Inc(MDVLQ) | COM NEW | 58406B202 | $707.4K | 117,897 | 0.8% |